CDDW™ Faculty Conflict of Interest Disclosure The Canadian Association of Gastroenterology (CAG) must ensure balance, independence, objectivity, and scientific rigour in all educational and scientific activities. Accordingly, CDDW™ faculty members are expected to disclose to the audience any potential, apparent or actual interests or connections that appear to influence their ability to act with integrity, objectivity, and independence on the assigned task. The intent of this disclosure summary is to provide the audience with information on the faculty interests/relationships that could influence interpretations, recommendations, and conclusions.

The following faculty have indicated that they do have relevant relationships of commercial interest

Afif, Waqqas Janssen (Consultant) (Company Advisory Board); Abbvie (Company Advisory Board) (Research Support); Takeda (Company Advisory Board) (Consultant); Pfizer (Company Advisory Board); Merck (Company Advisory Board); Ferring (Company Advisory Board); Shire (Company Advisory Board); Prometheus (Research Support); Theradiag (Research Support) (Consultant); Buhlmann (Research Support) Anderson, John Olympus (Other); Norgine (Speaker's Bureau) Andrews, Christopher Newstrike Inc. (Research Support) (Stockholder); Newstrike Inc. (Company Advisory Board); Allergan (Research Support) (Speaker's Bureau); Allergan (Company Advisory Board); Pendopharm (Speaker's Bureau); Lupin (Company Advisory Board); Jannsen (Research Support); Medtronic (Company Advisory Board); M Pharma Inc. (Company Advisory Board) (Stockholder) Armstrong, David Canadian Partnership Against Cancer (Consultant); AbbVie (Research Support) (Company Advisory Board); AbbVie (Speaker's Bureau) (Other); Allergan (Company Advisory Board) (Other); Ferring (Other); Janssen (Company Advisory Board) (Other); Lupin (Company Advisory Board) (Other); Pendopharm (Company Advisory Board) (Consultant); Pendopharm (Research Support) (Other); Pentax (Company Advisory Board) (Research Support); Pentax (Speaker's Bureau) (Consultant); Pfizer (Company Advisory Board) (Consultant); Shire (Speaker's Bureau) (Company Advisory Board); Takeda (Speaker's Bureau) (Consultant); Takeda (Company Advisory Board); Mylan (Speaker's Bureau) Asfaha, Samuel Lupin Pharma (Company Advisory Board) (None); Antibe Therapeutics (Stockholder); Allergan (Consultant) Beaton, Melanie Takeda (Other); Janssen (Speaker's Bureau); Abbvie (Company Advisory Board); Allergan (Company Advisory Board) Bercik, Premysl Nestec Switzerland (Consultant) (Research Support); Allergan (Consultant) (Company Advisory Board); IM HealthScience (Company Advisory Board); Innovate Biopharma (Company Advisory Board); LUPIN Pharma Canada Limited (Company Advisory Board) Bernstein, Charles Abbvie Canada (Company Advisory Board) (Speaker's Bureau); Ferring Canada (Company Advisory Board) (Speaker's Bureau); Janssen Canada (Company Advisory Board) (Other); Shire Canada (Company Advisory Board) (Speaker's Bureau); Pfizer Canada (Company Advisory Board); Takeda Canada (Company Advisory Board) (Other); Napo Pharmaceuticals (Company Advisory Board); Mylan Pharmaceuticals (Consultant); Abbvie Canada (Other); Shire Canada (Other) Bernstein, David Abbvie (Research Support) (Consultant); Abbvie (Speaker's Bureau) (Company Advisory Board); Gilead (Research Support) (Consultant); Gilead (Speaker's Bureau) (Company Advisory Board); Merck (Research Support) (Consultant); Merck (Speaker's Bureau) (Company Advisory Board) Bessissow, Talat Abbvie (Consultant); Abbvie (Speaker's Bureau); Janssen (Speaker's Bureau) (Consultant); Takeda (Speaker's Bureau) (Consultant); Ferring (Speaker's Bureau); Shire (Speaker's Bureau); Pendopharm (Speaker's Bureau); Pfizer (Consultant) (None); Pentax (Research Support) Beyak, Michael Abbvie (Speaker's Bureau) (Company Advisory Board); Pfizer (Company Advisory Board); Ferring (Speaker's Bureau) (Company Advisory Board) Buckley, Norman CIHR (Research Support); Health Canada (Research Support); Purdue (Research Support); Johnson and Johnson (Research Support); Michael G. DeGroote Pain Clinic (Speaker’s Bureau); CPSNS (Consultant) Camilleri, Michael Novartis (Research Support); Allergan (Research Support) Carman, Nicholas AbbVie Global (Research Support) Carpentier, Stephanie Abbvie (Company Advisory Board) (Consultant); Janssen (Consultant) Chavannes, Mallory Abbvie (Research Support) Chey, William Allergan (Consultant); Biomerica (Consultant); Coivin (Consultant); IM Health (Consultant); Ironwood (IM Health); Prometheus (Consultant); Nestle (Consultant); QOL Medical (Consultant); Salix (Consultant), American Neurogastroenterology and Motility Society (Board Member); American College of Gastroenterology (Board Member) Church, Peter Janssen (Consultant); Abbvie (Consultant) Duerksen, Donald Shire (Company Advisory Board) Enns, Robert Pfizer (Company Advisory Board); Ferring (Company Advisory Board); Pendopharm (Company Advisory Board) (Other); Abbvie (Other); Takeda (Other); Allergan (Other); Janssen (Other); Shire (Other); Olympus (Other) Forbes, Nauzer Pentax Canada (Research Support); Boston Scientific Canada (Speaker's Bureau)

All faculty claim a relationship with the CAG 1(5) CDDW™ Faculty Conflict of Interest Disclosure The Canadian Association of Gastroenterology (CAG) must ensure balance, independence, objectivity, and scientific rigour in all educational and scientific activities. Accordingly, CDDW™ faculty members are expected to disclose to the audience any potential, apparent or actual interests or connections that appear to influence their ability to act with integrity, objectivity, and independence on the assigned task. The intent of this disclosure summary is to provide the audience with information on the faculty interests/relationships that could influence interpretations, recommendations, and conclusions.

Ghia, Jean-Eric CBC / Radio Canada (Employee) (Consultant) Greenwald, Eric Abbvie (Company Advisory Board); Janssen (Company Advisory Board); Takeda (Company Advisory Board) Griffiths, Anne Abbvie (Company Advisory Board) (Speaker's Bureau); Janssen (Company Advisory Board) (Speaker's Bureau); Takeda (Consultant) (Other) Gruchy, Steven Abbvie (Speaker's Bureau) (Company Advisory Board); Janssen (Speaker's Bureau) (Company Advisory Board); Takeda (Company Advisory Board); Aptalis (Company Advisory Board); Ferring (Company Advisory Board) (Speaker's Bureau); Pendopharm (Company Advisory Board) Gulamhusein, Aliya Intercept (Company Advisory Board) Hirschfield, Gideon Intercept (Company Advisory Board); Cymabay (Company Advisory Board); Falk (Company Advisory Board); Gilead (Company Advisory Board); Novartis (Company Advisory Board); GSK (Company Advisory Board); GfK (Company Advisory Board) Hookey, Lawrence Ferring Pharmaceuticals (Speaker's Bureau) (Research Support) Huang, Jeannie Janssen (Research Support); Ferring (Research Support); Allergan (Research Support); AbbVie (Research Support) Huynh, Hien Janssen (Research Support); Abbvie (Company Advisory Board) Jacobson, Kevan Janssen (Company Advisory Board); AbbVie (Company Advisory Board); Ferring (Company Advisory Board); Engene (Stockholder); Janssen (Research Support) Jairath, Vipul AbbVie (Company Advisory Board), (Speaker’s Bureau), (Other); Takeda (Company Advisory Board), (Speaker’s Bureau), (Other); Pfizer (Other); Ferring (Speaker’s Bureau); Janssen (Company Advisory Board), (Speaker’s Bureau), (Other) Kelly, Ciarán Harvard Medical Faculty Faculty Physicians Celiac Center at BIDMC, Boston Harvard Medical School – Celiac Research Program (Employee); North American Society for the Study of Celiac Disease (Committee Member); Foundation for Celiac Disease Outcomes Measures (Committee Member); Current Opinion in Gastroenterology (Editor in Chief); Celimmune (Company Advisory Board); Cour Pharma (Company Advisory Board), (Stockholder); Glutenostics (Company Advisory Board), (Stockholder); Innovate (Company Advisory Board); ImmunogenX (Company Advisory Board); Takeda Pharmaceuticals (Company Advisory Board) Khadem, Forough Mitacs (Employee); New Media Manitoba (Board of Director member) Ko, Hin Hin Merck (Speaker's Bureau) (Company Advisory Board); Intercept (Speaker's Bureau) (Company Advisory Board); Lupin Pharmaceutical (Speaker's Bureau) (Company Advisory Board); Allergan (Speaker's Bureau); Pendopharm (Speaker's Bureau); Shire (Company Advisory Board); Gilead (Research Support); Abbvie (Research Support); Baxter (Speaker's Bureau) Lakatos, Peter Abbvie (Consultant) (Speaker's Bureau); Ferring (Speaker's Bureau); Genetech (Consultant); Jansen (Consultant); MSD (Consultant) (Speaker's Bureau); Pfizer (Consultant) (Speaker's Bureau); Roche (Consultant); Shire (Consultant) (Speaker's Bureau); Takeda (Consultant) Lam, Eric Olympus (Other); Pentax (Other) Lazarescu, Adriana Allergan (Company Advisory Board) (Speaker's Bureau) Le Foll, Bernard Bioprojet (Research Support); Allergan (Consultant); Prescott (Consultant); Indivior (Other); Canopy (Research Support); GW Pharmaceuticals (Research Support) Ling, Simon Bristol Myers Squibb (Research Support); Abbvie (Research Support) Liu, Louis AbbVie (Consultant) (Company Advisory Board); Allergan Canada (Consultant) (Company Advisory Board); Allergan Canada (Speaker's Bureau); Medtronic (Consultant) (Speaker's Bureau); Lupin Pharma Canada (Consultant) (Company Advisory Board); Takeda Canada Inc (Consultant) (Company Advisory Board) MacMillan, Mark AbbVie (Company Advisory Board) (Research Support); Janssen (Company Advisory Board) (None); Shire (Speaker's Bureau) (None); Takeda (Company Advisory Board) (None); Pfizer (Company Advisory Board) (None); Marshall, John AbbVie (Speaker's Bureau) (Company Advisory Board); Janssen (Speaker's Bureau) (Company Advisory Board); Takeda (Speaker's Bureau) (Company Advisory Board); Allergan (Speaker's Bureau) (Company Advisory Board); Shire (Speaker's Bureau) (Company Advisory Board); Ferring (Speaker's Bureau) (Company Advisory Board); Celltrion (Consultant); Pfizer (Consultant) (Company Advisory Board); Celgene (Consultant); Procter & Gamble (Speaker's Bureau) (Consultant); Merck (Company Advisory Board); Hospira (Consultant) (None); Lilly (Consultant); Pharmascience (Company Advisory Board) McGrath, Jerry Jansen (Company Advisory Board); Takeda (Company Advisory Board); Abbvie (Company Advisory Board); Pfizer (Company Advisory Board) McKenzie, Leanna Ferring (Consultant)

All faculty claim a relationship with the CAG 2(5) CDDW™ Faculty Conflict of Interest Disclosure The Canadian Association of Gastroenterology (CAG) must ensure balance, independence, objectivity, and scientific rigour in all educational and scientific activities. Accordingly, CDDW™ faculty members are expected to disclose to the audience any potential, apparent or actual interests or connections that appear to influence their ability to act with integrity, objectivity, and independence on the assigned task. The intent of this disclosure summary is to provide the audience with information on the faculty interests/relationships that could influence interpretations, recommendations, and conclusions.

Ménard, Charles Boston Scientific (Research Support); Pendopharm (Research Support) Moayyedi, Paul Allergan (Company Advisory Board) (Consultant); Takeda (Consultant); Salix (Company Advisory Board); AstraZeneca (Chair of Gastroenterology) Murray, Karen Gilead (Research Support) (Consultant); Merck (Research Support) (Stockholder); NIH (Research Support); Shire (Research Support) Nasser, Yasmin Allergan (Company Advisory Board) Otley, Anthony Janssen (Research Support) (Company Advisory Board); AbbVie (Research Support) (Company Advisory Board); Eli Lily (Consultant); Astellas (Research Support); Merck (Research Support); Takeda (Research Support) Panaccione, Remo Abbvie (Consultant) (Company Advisory Board); (Speaker's Bureau) (Research Support); Janssen (Consultant) (Company Advisory Board); (Speaker's Bureau) (Research Support); Takeda (Consultant) (Company Advisory Board); (Speaker's Bureau) (Research Support); Pfizer (Consultant) (Company Advisory Board) (Speaker's Bureau); Shire (Consultant) (Company Advisory Board); Shire (Speaker's Bureau); Ferring (Consultant) (Company Advisory Board); Ferring (Speaker's Bureau); Amgen (Consultant) (Company Advisory Board); Allergan (Consultant) (Company Advisory Board); Celgene (Consultant) (Company Advisory Board) Plamondon, Sophie Janssen (Speaker's Bureau); Abbvie (Speaker's Bureau) (Research Support); Takeda (Speaker's Bureau); Shire (Speaker's Bureau) Puglia, Marco Novo Nordisk (Research Support); Intercept (Research Support) (Company Advisory Board); Gilead (Research Support) Rahman, Adam Fresenius Kabi (Consultant) (Speaker's Bureau); Shire (Speaker's Bureau) (Company Advisory Board); Baxter (Consultant); Abbott (Research Support) (Consultant); Raman, Maitreyi Baxter (Speaker's Bureau); Shire (Company Advisory Board) (Speaker's Bureau) Ramji, Alnoor Abbvie (Speaker's Bureau, Consultant, Research Support, Company Advisory Board); BMS (Consultant, Research Support); Gilead (Speaker's Bureau, Consultant, Research Support, Company Advisory Board); Intercept (Company Advisory Board, Research Support); Merck (Speaker's Bureau, Consultant, Research Support); Jansen (Research Support); Lupin (Company Advisory Board) Rossos, Peter eHealth Ontario (Board member); Canada Health Infoway (Grant) Rostom, Alaa Olympus (Other) Santamaria, Pere Parvus Therapeutics Inc (Stockholder) (Employee) Seow, Cynthia Janssen (Company Advisory Board) (Speaker's Bureau); Abbvie (Company Advisory Board) (Speaker's Bureau); Takeda (Company Advisory Board); Shire (Company Advisory Board); Ferring (Company Advisory Board) Sharkey, Keith Ironwood Pharmaceuticals (Research Support); Takeda Pharmaceuticals (Research Support) (Consultant); Lallemand Health Solutions (Research Support); MedImmune (Research Support) Shiffman, Mitchell Abbvie (Company Advisory Board) (Speaker's Bureau) (Research Support); Bayer (Speaker's Bureau); Bristol-Myers- Squibb (Company Advisory Board) (Speaker's Bureau) (Research Support); Conatus (Research Support); CymaBay (Research Support); Daiichi Sankyo (Speaker's Bureau); Exalenz (Research Support); Galectin (Research Support); Genfit (Research Support); Gilead (Speaker's Bureau) (Research Support) (Company Advisory Board); Intercept (Speaker's Bureau) (Research Support) (Company Advisory Board); Immuron (Research Support); NGMBio (Research Support); Novartis (Research Support); Optum Rx (Consultant); Salix (Speaker's Bureau) (Company Advisory Board); Shire (Research Support) Shneider, Benjamin Bristol Myers Squibb (Consultant) (Stockholder) Siegal, Deborah Servier, Inc (Company Advisory Board); Bayer (Company Advisory Board) Singh, Harminder Merck (Research Support) (None); Pendopharm (Company Advisory Board); Ferring Canada (Company Advisory Board) Sultanian, Richard Boston Scientific (Consultant); Cook Medical Inc. (Consultant) Surette, Michael Takeda Pharmaceuticals (Consultant) Szigethy, Eva Abbvie (Consultant); iHope Network Inc. (Consultant); APPI (Other) Targownik, Laura Abbvie (Research Support); Takeda (Speaker's Bureau) (Company Advisory Board); Janssen (Speaker's Bureau) (Company Advisory Board); Pfizer (Company Advisory Board); Janssen (Research Support) Tse, Yvonne AbbVie (Company Advisory Board); Metronics (Consultant) Tsien, Cynthia Lupin (Speaker's Bureau); Intercept (Company Advisory Board); Mallinckrodt (Research Support)

All faculty claim a relationship with the CAG 3(5) CDDW™ Faculty Conflict of Interest Disclosure The Canadian Association of Gastroenterology (CAG) must ensure balance, independence, objectivity, and scientific rigour in all educational and scientific activities. Accordingly, CDDW™ faculty members are expected to disclose to the audience any potential, apparent or actual interests or connections that appear to influence their ability to act with integrity, objectivity, and independence on the assigned task. The intent of this disclosure summary is to provide the audience with information on the faculty interests/relationships that could influence interpretations, recommendations, and conclusions.

Turnbull, Geoffrey Covidien/Medtronic (Speaker's Bureau); Shire (Company Advisory Board); Allergan (Consultant) (Company Advisory Board) Turner, Nancy United Sorghum Checkoff Program (Research Support); California Dried Plum Board (Research Support); NASA (Research Support) Ukabam, Sylvester Lupin Pharma (Company Advisory Board); Intercept Pharma (Company Advisory Board) Upton, Julia DBV (Research Support); Aimmune (Research Support); Food Allergy Canada (Consultant); Sickkids Foundation (Research Support); Immunodeficiency Canada (Company Advisory Board); Hospital for Sick Children (Employee); Chair, Anaphylaxis and Food Allergy, Canadian Society of Allergy and Clinical Immunology (Other) Vallance, Bruce Qu Biologics (Research Support) Valori, Roland Director of AnderVal Ltd, an endoscopy training company (Consultant) Van Limbergen, Johan Nestle (Company Advisory Board) (Research Support); Janssen (Company Advisory Board) (Research Support); Abbvie (Research Support) (Company Advisory Board) Vanner, Stephen Allergan (Speaker's Bureau) (Company Advisory Board); Ferring (Research Support) Verdu, Elena Nestle Research Center (Research Support); Biocodex (Company Advisory Board); Inovate (Consultant) Vos, Miriam Allergan (Consultant); Aegerion (Consultant); Immuron (Company Advisory Board) (Research Support); Intercept (Consultant); Shire (Consultant) (Research Support); Target Pharmasolutions (Company Advisory Board) (Research Support); Bristol-Myers Squibb (Company Advisory Board); Boehringer Ingelheim (Consultant); AMRA (Company Advisory Board) (Research Support); Labcorp (Research Support) Wilschanski, Michael Vertex Pharmaeuticals (Consultant) (Research Support); Anthera Pharmaceuticals (Consultant) (Research Support); PTC Therapeutics (Company Advisory Board); Alcresta Therapeutics (Consultant) Wong, Clarence Pendopharm (Company Advisory Board) (Speaker's Bureau); Takeda (Company Advisory Board) (Speaker's Bureau); Medtronic (Consultant); Allergan (Company Advisory Board) (Speaker's Bureau); Ferring (Company Advisory Board); Alberta Health Services (Employee)

All faculty claim a relationship with the CAG 4(5) CDDW™ Faculty Conflict of Interest Disclosure The Canadian Association of Gastroenterology (CAG) must ensure balance, independence, objectivity, and scientific rigour in all educational and scientific activities. Accordingly, CDDW™ faculty members are expected to disclose to the audience any potential, apparent or actual interests or connections that appear to influence their ability to act with integrity, objectivity, and independence on the assigned task. The intent of this disclosure summary is to provide the audience with information on the faculty interests/relationships that could influence interpretations, recommendations, and conclusions.

The following faculty have indicated that they do not have relevant relationships of commercial interest

Aguilar, Esther Gruenheid, Samantha Lomax, Alan Ratcliffe, Elyanne Alhazzani, Waleed Halder, Smita Lu, Cathy Silverman, Jason Allard, Johane Hart, Lara MacIntosh, Donald Sly, Laura Arrieta, Marie-Claire Heitman, Steven Marcon, Peggy Snider, Janel Avitzur, Yaron Hilzenrat, Nir Marwaha, Nicky Subramanian, Ram Barkey, Janice Hirota, Simon McCoy, Kathy Summers, Sue Bechara, Robert Huizinga, Jan McKay, Derek Telford, Jennifer Benchimol, Eric Jimenez-Rivera, Carolina Mellon, Trina Tinmouth, Jill Blennerhassett, Michael Jones, Nicola Mosko, Jeffrey Tse, Frances Boland, Margaret Kaplan, Gilaad Muise, Aleixo Turner, Justine Boudreau, François Karvellas, Constantine Nair, Sabarinath Turner, Nancy Chen, Yen-I Kaser, Arthur Nguyen, Geoffrey Valentino, Pamela Chiba, Naoki Keefer, Laurie Norton, Elizabeth Veldhuyzen van Zanten, Cooper, Mary Anne Kim, Young-In Osborne, Lisa Sander Donnellan, Fergal Laffin, Michael Paterson, William Walsh, Catharine Durno, Carol Lakatos, Peter Perreault, Nathalie Waschke, Kevin Farina, Dana Lebwohl, Benjamin Philpott, Dana Winer, Dan Faure, Christophe Leddin, Desmond Pinto-Sanchez, Maria Yan, Brian Gibson, Deanna Lee, Kate Piscione, Tino Yeung, Alfred Girardin, Stephen Leontiadis, Grigorios Qumosani, Karim Zachos, Mary

All faculty claim a relationship with the CAG 5(5)